Y. Yoo, Computing in Everyday Life: A Call for Research on Experiential Computing, MIS Quarterly, vol.34, pp.213-231, 2010.

. Pricewaterhousecoopers, Pharma 2020: The Vision ? Which Path Will You Take, PricewaterhouseCoopers, 2007.

M. Goozner, The $800 Million Pill ? The Truth behind the Cost of New Drugs, 2004.

W. J. Orlikowski, Using Technology and Constituting Structures: A Practice Lens for Studying Technology in Organizations, Organization Science, vol.11, issue.4, pp.404-428, 2000.
DOI : 10.1287/orsc.11.4.404.14600

T. Cornford, I. Savage, Y. Jani, B. D. Franklin, N. Barber et al., Learning Lessons from Electronic Prescribing Implementations in Secondary Care, Studies in Health Technology and Informatics, vol.160, pp.233-237, 2009.

K. Shoenbill, N. Fost, U. Tachinardi, and E. A. Mendonca, Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations, Journal of the American Medical Informatics Association, vol.21, issue.1, pp.171-180, 2014.
DOI : 10.1136/amiajnl-2013-001694

G. C. Bell, K. R. Crews, M. R. Wilkinson, C. E. Haidar, J. K. Hicks et al., Development and use of active clinical decision support for preemptive pharmacogenomics, Journal of the American Medical Informatics Association, vol.21, issue.e1, pp.93-99, 2014.
DOI : 10.1136/amiajnl-2013-001993

A. D. Hingorani, D. A. Van-der-windt, R. D. Riley, K. Abrams, K. G. Moons et al., Prognosis research strategy (PROGRESS) 4: Stratified medicine research, Prognosis Research Strategy (PROGRESS) 4: Stratified Medicine Research, p.5793, 2013.
DOI : 10.1136/bmj.e5793

M. A. Hamburg and F. S. Collins, The Path to Personalized Medicine, New England Journal of Medicine, vol.363, issue.4, pp.301-304, 2010.
DOI : 10.1056/NEJMp1006304

S. Schleidgen, C. Klingler, T. Bertram, W. Rogowski, and G. Marckmann, What is personalized medicine: sharpening a vague term based on a systematic literature review, BMC Medical Ethics, vol.58, issue.1, p.55, 2013.
DOI : 10.1136/bmj.b2700

R. Chen, G. I. Mias, J. Li-pook-than, L. Jiang, H. Y. Lam et al., Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes, Cell, vol.148, issue.6, pp.1293-1307, 2012.
DOI : 10.1016/j.cell.2012.02.009

N. Council and . Bioethics, Medical Profiling and Online Medicine: The Ethics of 'Personalised Healthcare' in a Consumer Age, Nuffield Council on Bioethics, 2010.

C. Freifeld, J. Brownstein, C. Menone, W. Bao, R. Filice et al., Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter, Drug Safety, vol.471, issue.Suppl 1, pp.343-350, 2014.
DOI : 10.1007/s40264-014-0155-x

B. R. Goldspiel, W. A. Flegel, G. Dipatrizio, T. Sissung, S. D. Adams et al., Integrating pharmacogenetic information and clinical decision support into the electronic health record, Journal of the American Medical Informatics Association, vol.21, issue.3, pp.522-528, 2014.
DOI : 10.1136/amiajnl-2013-001873

T. Almuzaini, I. Choonara, and H. Sammons, Substandard and counterfeit medicines: a systematic review of the literature, BMJ Open, vol.3, issue.8, p.2923, 2013.
DOI : 10.1136/bmjopen-2013-002923

G. E. Marcus and E. Saka, Assemblage, Theory, Culture & Society, vol.23, issue.2-3, pp.101-106, 2006.
DOI : 10.1177/0263276406062573

D. Landa and M. , Intensive Science and Virtual Philosophy, 2002.

D. Smith and J. Protevi, Gilles Deleuze The Stanford Encyclopedia of Philosophy (Spring 2013 edn, 1954.

G. Chatellier, E. Zapletal, D. Lemaitre, J. Menard, and P. Degoulet, The number needed to treat: a clinically useful nomogram in its proper context, BMJ, vol.312, issue.7028, pp.426-429, 1996.
DOI : 10.1136/bmj.312.7028.426

L. Toms, S. Derry, R. A. Moore, and H. J. Mcquay, Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults, Cochrane Database of Systematic Reviews, vol.70, issue.4, p.1547, 2009.
DOI : 10.1002/14651858.CD001547.pub2

Y. Yoo, Digital Materiality and the Emergence of an Evolutionary Science of the Artificial, Materiality and Organizing: Social Interaction in a Technological World, pp.134-154, 2012.
DOI : 10.1093/acprof:oso/9780199664054.003.0007

D. Quah, Digital Goods and the New Economy. CEP Discussion Paper CEPDP0563. Centre for Economic Performance, London School of Economics and Political Science, 2003.

D. Blumenthal and M. Tavenner, The ???Meaningful Use??? Regulation for Electronic Health Records, New England Journal of Medicine, vol.363, issue.6, pp.501-504, 2010.
DOI : 10.1056/NEJMp1006114

B. E. Dixon, A. M. Jabour, E. O. Phillips, and D. G. Marrero, An informatics approach to medication adherence assessment and improvement using clinical, billing, and patient-entered data, Journal of the American Medical Informatics Association, vol.21, issue.3, pp.517-521, 2014.
DOI : 10.1136/amiajnl-2013-001959

K. Kawamoto, D. Lobach, H. Willard, and G. Ginsburg, A national clinical decision support infrastructure to enable the widespread and consistent practice of genomic and personalized medicine, BMC Medical Informatics and Decision Making, vol.298, issue.9, p.17, 2009.
DOI : 10.1001/jama.298.14.1682

B. M. Welch and K. Kawamoto, Clinical decision support for genetically guided personalized medicine: a systematic review, Journal of the American Medical Informatics Association, vol.20, issue.2, pp.388-400, 2013.
DOI : 10.1136/amiajnl-2012-000892

M. B. Buntin, S. H. Jain, and D. Blumenthal, Health Information Technology: Laying The Infrastructure For National Health Reform, Health Affairs, vol.29, issue.6, pp.1214-1219, 2010.
DOI : 10.1377/hlthaff.2010.0503

S. L. Vargo and R. F. Lusch, Evolving to a New Dominant Logic for Marketing, Journal of Marketing, vol.68, issue.1, pp.1-17, 2004.
DOI : 10.1509/jmkg.68.1.1.24036

L. J. Lesko, I. Zineh, and S. M. Huang, What Is Clinical Utility and Why Should We Care?, Clinical Pharmacology & Therapeutics, vol.88, issue.6, pp.729-733, 2010.
DOI : 10.1097/GIM.0b013e3181a2743e

K. Claxton, A. Briggs, M. J. Buxton, A. J. Culyer, C. Mccabe et al., Value based pricing for NHS drugs: an opportunity not to be missed?, BMJ, vol.336, issue.7638, pp.251-254, 2008.
DOI : 10.1136/bmj.39434.500185.25

K. Claxton, M. Sculpher, and S. Carroll, Value-Based Pricing For Pharmaceuticals: Its Role, Specification and Prospects in a Newly Devolved NHS, CHE Research Paper, vol.60, 2011.

J. Lewis, W. Lipworth, and I. Kerridge, Ethics, Evidence and Economics in the Pursuit of ???Personalized Medicine???, Journal of Personalized Medicine, vol.4, issue.2, pp.137-146, 2014.
DOI : 10.3390/jpm4020137

S. Schneeweiss, Learning from Big Health Care Data, New England Journal of Medicine, vol.370, issue.23, pp.2161-2163, 2014.
DOI : 10.1056/NEJMp1401111

Z. Ren, M. Davidian, S. L. George, R. M. Goldberg, F. A. Wright et al., Research Methods for Clinical Trials in Personalized Medicine: A Systematic Review, Lost In Translation: Barriers to Incentives for Translational Research in Medical Sciences, pp.659-684, 2014.
DOI : 10.1142/9789814489072_0025

P. Hawe, A. Shiell, and T. Riley, Complex interventions: how "out of control" can a randomised controlled trial be?, BMJ, vol.328, issue.7455, pp.1561-1563, 2004.
DOI : 10.1136/bmj.328.7455.1561

B. M. Psaty and A. M. Breckenridge, Mini-Sentinel and Regulatory Science ??? Big Data Rendered Fit and Functional, New England Journal of Medicine, vol.370, issue.23, pp.2165-2167, 2014.
DOI : 10.1056/NEJMp1401664

S. Bhattacharya, Up to 140,000 Heart Attacks Linked to Vioxx, New Scientist, p.25, 2005.

D. Singh, Merck withdraws arthritis drug worldwide, BMJ, vol.329, issue.7470, p.816, 2004.
DOI : 10.1136/bmj.329.7470.816-a

G. J. Brewer, Drug development for orphan diseases in the context of personalized medicine, Translational Research, vol.154, issue.6, pp.314-322, 2009.
DOI : 10.1016/j.trsl.2009.03.008

T. Merlin, C. Farah, C. Schubert, A. Mitchell, J. E. Hiller et al., Assessing Personalized Medicines in Australia, Medical Decision Making, vol.41, issue.11, pp.333-342, 2013.
DOI : 10.1377/hlthaff.14.4.143

M. G. Niezen, R. Bal, and A. De-bont, Reconfiguring Policy and Clinical Practice: How Databases Have Transformed the Regulation of Pharmaceutical Care?, Science, Technology & Human Values, vol.38, issue.1, pp.44-66, 2013.
DOI : 10.1177/0162243911435277

H. Burstin, The Journey to Electronic Performance Measurement, Annals of Internal Medicine, vol.158, issue.2, pp.131-132, 2013.
DOI : 10.7326/0003-4819-158-2-201301150-00009

L. Gitelman, Raw Data Is an Oxymoron, 2013.

A. Beaulieu, Voxels in the Brain Neuroscience, Informatics and Changing Notions of Objectivity. Social Studies of Science, vol.31, pp.635-680, 2001.

A. Beaulieu, From brainbank to database: the informational turn in the study of the brain, Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, vol.35, issue.2, pp.367-390, 2004.
DOI : 10.1016/j.shpsc.2004.03.011